| Title |
Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer
|
|---|---|
| Published in |
Breast Cancer Research and Treatment, November 2016
|
| DOI | 10.1007/s10549-016-4059-6 |
| Pubmed ID | |
| Authors |
Xiaoxian Li, Jing Yang, Limin Peng, Aysegul A. Sahin, Lei Huo, Kevin C. Ward, Ruth O’Regan, Mylin A. Torres, Jane L. Meisel |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 377 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 377 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 45 | 12% |
| Student > Ph. D. Student | 43 | 11% |
| Student > Bachelor | 41 | 11% |
| Researcher | 30 | 8% |
| Other | 16 | 4% |
| Other | 41 | 11% |
| Unknown | 161 | 43% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 68 | 18% |
| Medicine and Dentistry | 62 | 16% |
| Pharmacology, Toxicology and Pharmaceutical Science | 15 | 4% |
| Agricultural and Biological Sciences | 12 | 3% |
| Immunology and Microbiology | 10 | 3% |
| Other | 47 | 12% |
| Unknown | 163 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 July 2023.
All research outputs
#2,324,575
of 26,017,215 outputs
Outputs from Breast Cancer Research and Treatment
#310
of 5,117 outputs
Outputs of similar age
#43,840
of 421,854 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#5
of 64 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,117 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one has done particularly well, scoring higher than 93% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 421,854 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 64 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.